Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Regadenoson

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,548,904Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1DR REDDYS

    02 1ACCORD HLTHCARE

    03 1APOTEX

    04 1ASTELLAS

    05 1BAXTER HLTHCARE CORP

    06 1EUGIA PHARMA

    07 1GE HEALTHCARE

    08 1GLAND PHARMA LTD

    09 1HIKMA

    10 1HOSPIRA

    11 1IMS LTD

    12 1INDIES PHARMA

    13 1MEITHEAL

    14 1MYLAN

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    DR REDDYS

    India
    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    REGADENOSON

    Brand Name : REGADENOSON

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 0.4MG/5ML (0.08MG/ML)

    Approval Date : 2022-04-11

    Application Number : 213210

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ACCORD HLTHCARE

    United Kingdom
    2024 ACI Convention
    Not Confirmed
    arrow

    ACCORD HLTHCARE

    United Kingdom
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    REGADENOSON

    Brand Name : REGADENOSON

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 0.4MG/5ML (0.08MG/ML)

    Approval Date : 2022-04-11

    Application Number : 213236

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    APOTEX

    Canada
    2024 ACI Convention
    Not Confirmed
    arrow

    APOTEX

    Canada
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    REGADENOSON

    Brand Name : REGADENOSON

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 0.4MG/5ML (0.08MG/ML)

    Approval Date : 2022-04-11

    Application Number : 207604

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    ASTELLAS

    Japan
    2024 ACI Convention
    Not Confirmed
    arrow

    ASTELLAS

    Japan
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code : AP

    REGADENOSON

    Brand Name : LEXISCAN

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 0.4MG/5ML (0.08MG/ML)

    Approval Date : 2008-04-10

    Application Number : 22161

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    GLAND PHARMA LTD

    India
    2024 ACI Convention
    Not Confirmed
    arrow

    GLAND PHARMA LTD

    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    REGADENOSON

    Brand Name : REGADENOSON

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 0.4MG/5ML (0.08MG/ML)

    Approval Date : 2022-07-12

    Application Number : 207320

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    HIKMA

    United Kingdom
    2024 ACI Convention
    Not Confirmed
    arrow

    HIKMA

    United Kingdom
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    REGADENOSON

    Brand Name : REGADENOSON

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 0.4MG/5ML (0.08MG/ML)

    Approval Date : 2023-02-02

    Application Number : 215827

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    HOSPIRA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    HOSPIRA

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    REGADENOSON

    Brand Name : REGADENOSON

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 0.4MG/5ML (0.08MG/ML)

    Approval Date : 2022-08-31

    Application Number : 214349

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    IMS LTD

    Italy
    2024 ACI Convention
    Not Confirmed
    arrow

    IMS LTD

    Italy
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    REGADENOSON

    Brand Name : REGADENOSON

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 0.4MG/5ML (0.08MG/ML)

    Approval Date : 2022-05-23

    Application Number : 214252

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    MEITHEAL

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    MEITHEAL

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    REGADENOSON

    Brand Name : REGADENOSON

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 0.4MG/5ML (0.08MG/ML)

    Approval Date : 2022-04-11

    Application Number : 212806

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    MYLAN

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    MYLAN

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    REGADENOSON

    Brand Name : REGADENOSON

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 0.4MG/5ML (0.08MG/ML)

    Approval Date : 2023-04-04

    Application Number : 213856

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF